Cancer pathways can potentially improve patient outcomes and reduce costs. Recent concerns about pathway adoption deserve attention, including excessive administrative burden to clinics.
Bernardo Haddock Lobo Goulart, MD, MS
Advertisement
Articles by Bernardo Haddock Lobo Goulart, MD, MS
Advertisement
Latest Updated Articles
- Cancer Care Pathways: Hopes, Facts, and Concerns
Published: April 13th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology
5
